| scholarly article | Q13442814 |
| P50 | author | Tebeb Gebretsadik | Q90344341 |
| P2093 | author name string | Paolo Raggi | |
| Annette Oeser | |||
| C Michael Stein | |||
| Young Hee Rho | |||
| Ayumi Shintani | |||
| Aihua Bian | |||
| Vivian K Kawai | |||
| Joseph F Solus | |||
| Ratchaya Lertnawapan | |||
| P2860 | cites work | Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study | Q24646339 |
| Cystatin C and the risk of death and cardiovascular events among elderly persons | Q28251528 | ||
| Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement | Q28256758 | ||
| Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome | Q28287352 | ||
| Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). | Q33357921 | ||
| Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance | Q33889802 | ||
| Association of mild to moderate kidney dysfunction and coronary calcification | Q36667225 | ||
| Cystatin C--a paradigm of evidence based laboratory medicine. | Q36869663 | ||
| Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance | Q37176841 | ||
| Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study) | Q37259589 | ||
| Indexes of kidney function and coronary artery and abdominal aortic calcium (from the Framingham Offspring Study) | Q37259595 | ||
| Renal disorders in rheumatoid arthritis | Q37970133 | ||
| Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study | Q46783054 | ||
| Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis | Q79698753 | ||
| Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 2297-2300 | |
| P577 | publication date | 2011-08-15 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Cystatin C, renal function, and atherosclerosis in rheumatoid arthritis | |
| P478 | volume | 38 |
| Q54236399 | A purification method for tag-free human cystatin C recombinant protein expressed in Escherichia coli. |
| Q34081242 | Cardiovascular involvement in autoimmune diseases |
| Q35551347 | Cystatin C and long term risk of community-acquired sepsis: a population-based cohort study |
| Q35746107 | Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus |
| Q38987127 | Human cystatin C monomer, dimer, oligomer, and amyloid structures are related to health and disease. |
| Q37281848 | Inflammation and hypertension in rheumatoid arthritis |
| Q38098935 | Novel risk factors for cardiovascular disease in rheumatoid arthritis |
| Q41445553 | Prevalence of Renal Impairment in Patients With Rheumatoid Arthritis: Results From a Cross-Sectional Multicenter Study |
| Q36001551 | Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative |
| Q47638003 | Serum cystatin C is associated with kidney function but not with cardiovascular risk factors or subclinical atherosclerosis in patients with Systemic Lupus Erythematosus |
Search more.